Skip to main content

Table 1 Demographic data for matched pairs consisting of individuals with schizophrenia and non-psychiatric controls.

From: Altered gene expression in the superior temporal gyrus in schizophrenia

Pair Gender Age (years) (sz/cntrl) Medication (CPE) (mg/day) Duration of Illness (years) Frozen Hemisphere Cause of Death (sz/cntrl) PMI (hours) (sz/cntrl) pH (sz/cntrl)
1 M 51/50 100 24 L ischaemic heart disease/ischaemic heart disease 21/19 6.02/6.26
2 M 57/58 unknown 26 L cardiac arrhythmia/ischaemic heart disease 33/38 6.4/6.5
3 M 52/59 450 31 R ischaemic heart disease/coronary thrombosis 8/20 6.1/6.56
4 M 44/43 500 17 L Suicide/thrombotic coronary artery occlusion 35/13 6.55/6.43
5 M 30/34 130–520 3.5 L Suicide/acute exacerbation of asthma 24/20.5 6.6/6.73
6 M 32/38 780 13 L Suicide/atherosclerotic cardiovascular disease 25/13.5 6.24/6.26
7 M 51/46 300–1300 30 R ischaemic heart disease/cardiac arrest 18/25 6.62/6.7
8 F 67/70 150–1100 46 R Emphema/ischaemic heart disease 27/30 6.2/6.8
9 M 75/73 200–1200 44 L ischaemic heart disease/respiratory arrest 36/10 6.4/6.2
10 M 54/56 50–600 35 R Coronary artery thrombosis/cardiac arrest 27/37 6.2/6.8
11 F 61/56 800–1500 42 R ischaemic heart disease/pulmonary thromboembolus 49/23 6.7/6.7
12 M 67/69 200–2400 41 R ischaemic heart disease/cardiovascular disease 5/16 6.4/6.6
13 M 57/56 225–975 17 R cardiovascular disease/Cardiac atheroma 48/24 6.7/6.5
Means SZ Control 53.7 ± 13.0
54.5 ± 12.1
*637.9 ± 342.7 28.4 ± 13.2    27.4 ± 13.2
22.2 ± 8.7
6.4 ± 0.2
6.5 ± 0.2
  1. *calculated using the mean CPE dosage for each matched pair.